newsfilter
← Latest News
Business Wire·

Acorda Therapeutics Will Not Use Shares for December 2022 $6.2 Million Interest Payment on Secured Debt

Acorda Therapeutics, Inc. (NASDAQ:ACOR) today announced that it will not use its common stock to make the approximately $6.2 million interest payment due on December 1, 2022, as provided for under its Convertible Senior